QSANT Trademark

Trademark Overview

On Monday, August 24, 2020, a trademark application was filed for QSANT with the United States Patent and Trademark Office. The USPTO has given the QSANT trademark a serial number of 90133615. The federal status of this trademark filing is REGISTERED as of Tuesday, January 10, 2023. This trademark is owned by NephroSant, Inc.. The QSANT trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic reagents and assays for testing risk of allograft rejection
qsant

General Information

Serial Number90133615
Word MarkQSANT
Filing DateMonday, August 24, 2020
Status700 - REGISTERED
Status DateTuesday, January 10, 2023
Registration Number6950552
Registration DateTuesday, January 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2021

Trademark Statements

Goods and ServicesMedical diagnostic reagents and assays for testing risk of allograft rejection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code005
First Use Anywhere DateThursday, April 1, 2021
First Use In Commerce DateThursday, April 1, 2021

Trademark Owner History

Party NameNephroSant, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameNephroSant, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameNephroSant, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 5, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 19, 2022USE AMENDMENT FILED
Wednesday, November 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 19, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 1 GRANTED
Tuesday, April 26, 2022SOU EXTENSION 1 FILED
Tuesday, April 26, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 30, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, December 26, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, December 26, 2020LETTER OF SUSPENSION E-MAILED
Saturday, December 26, 2020SUSPENSION LETTER WRITTEN
Saturday, December 19, 2020ASSIGNED TO EXAMINER
Saturday, September 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 27, 2020NEW APPLICATION ENTERED

Related Keywords

qsant risk allograft rejection testing assays diagnostic reagents medical